Literature DB >> 11310625

Perfusion magnetic resonance abnormalities in patients with sickle cell disease.

F J Kirkham1, F Calamante, M Bynevelt, D G Gadian, J P Evans, T C Cox, A Connelly.   

Abstract

Neurological complications are common in sickle cell disease (SCD). However, it is often difficult to relate the clinical presentation to conventional neuroimaging, because subclinical infarction is common and stroke has been described in the absence of large-vessel disease. We studied 48 patients with SCD aged 4-34 (median 13) years with T2-weighted, diffusion and perfusion magnetic resonance imaging (MRI) and with MR angiography. Forty-four underwent transcranial Doppler (TCD). Abnormalities on perfusion imaging were seen in 25 cases, 24 of whom had been symptomatic. The remaining patient had evidence of executive dysfunction and reduced perfusion in the frontal lobes. The perfusion abnormality was larger than the area of infarction in 9 patients and was seen in an arterial distribution with no infarction in a further 9. In 3 patients with transient ischemic attacks, perfusion abnormalities were demonstrated in the absence of any other neuroimaging abnormalities, and perfusion changes were seen in 3 others despite normal MR angiography and TCD. Perfusion abnormalities are associated with neurological symptoms in patients with SCD, whether or not MRI, MR angiography, and TCD are abnormal. It is likely that this technique will guide management in individual patients.

Entities:  

Mesh:

Year:  2001        PMID: 11310625

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  16 in total

1.  Stroke is an important paediatric illness.

Authors:  W K Kling Chong; Dawn E Saunders; Vijeya Ganesan
Journal:  Pediatr Radiol       Date:  2003-11-28

2.  Cerebrovascular disease associated with sickle cell pulmonary hypertension.

Authors:  Gregory J Kato; Matthew Hsieh; Roberto Machado; James Taylor; Jane Little; John A Butman; Tanya Lehky; John Tisdale; Mark T Gladwin
Journal:  Am J Hematol       Date:  2006-07       Impact factor: 10.047

3.  MRI/MRA evaluation of sickle cell disease of the brain.

Authors:  Robert A Zimmerman
Journal:  Pediatr Radiol       Date:  2005-02-10

Review 4.  Neuroimaging findings in sickle cell disease.

Authors:  S C Thust; C Burke; A Siddiqui
Journal:  Br J Radiol       Date:  2014-05-21       Impact factor: 3.039

5.  Noninvasive optical assessment of resting-state cerebral blood flow in children with sickle cell disease.

Authors:  Seung Yup Lee; Kyle R Cowdrick; Bharat Sanders; Eashani Sathialingam; Courtney E McCracken; Wilbur A Lam; Clinton H Joiner; Erin M Buckley
Journal:  Neurophotonics       Date:  2019-08-19       Impact factor: 3.593

Review 6.  Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability.

Authors:  Fenella J Kirkham; Avijit K Datta
Journal:  Dev Sci       Date:  2006-07

Review 7.  Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia.

Authors:  Michael R DeBaun; F Daniel Armstrong; Robert C McKinstry; Russell E Ware; Elliot Vichinsky; Fenella J Kirkham
Journal:  Blood       Date:  2012-02-21       Impact factor: 22.113

8.  Stroke in Children with Sickle Cell Disease.

Authors:  Fenella J. Kirkham; Michael R. DeBaun
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

Review 9.  Inherited and acquired risk factors for arterial ischemic stroke in childhood.

Authors:  Giuseppe Lippi; Massimo Franchini; Martina Montagnana; Gian Luca Salvagno; Giovanni Targher; Gian Cesare Guidi
Journal:  J Thromb Thrombolysis       Date:  2008-02-10       Impact factor: 2.300

10.  Arterial spin labeling characterization of cerebral perfusion during normal maturation from late childhood into adulthood: normal 'reference range' values and their use in clinical studies.

Authors:  Patrick W Hales; Jamie M Kawadler; Sarah E Aylett; Fenella J Kirkham; Christopher A Clark
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-05       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.